Department of Medical Science, Ph.D.
Dr. Seok has demonstrated physiological roles of DEXRAS1 in bone morphology and bone formation. In addition, Dr. Seok has investigated molecular mechanisms of how DEXRAS1 plays a key role to modulate pathogenesis of Cushing Syndromes using animal models. After Ph.D. program, she returned to Yonsei University College of Nursing to pursue her professional academic career. Dr. Seok has been appointed as Assistant Professor at Ewha Womans University College of Nursing.
Department of Medical Science, Ph.D.
Dr. Yoon has investigated metabolic pathways of various cancer cells including gastric cancer to survive under environmental stress. With metabolic flux, Dr. Yoon has demonstrated that chemo-resistant gastric cancer has unique nutrient-uptake mechanism to survive in the condition of nutritional stress. As being trained to analyze immune profile in various tissues using multiomics, Dr. Yoon has developed her professional carreer in immunology and has been appointed as Assistant Professor at Dept of Microbiology, Yonsei University College of Medicine.
Department of Medical Science, Ph.D. (March 2018~August 2023)
Dr. Kim has interested in the molecular mechanisms of how cancer cells survive under environmental stress such as nutritional stress. As trained to analyze transcriptomics, Dr. Kim has pursued to explore her research field into genomics in the basis of whole genome sequencing data. After being trained with metabolic plasticity in cancers, metabolic syndromes with transcriptomics and genomics, Dr. Kim joined the laboratory of Dr. Alan Saltiel (Univ. of California at San Diego) as Postdoctoral Research Associate from February 2024.
Department of Medical Science, Ph.D. (September 2018~August 2023)
Dr. Hwang has been trained to investigate the molecular mechanisms of tumorigenesis and migration in gastric cancer. In addition, Dr. Hwang has been trained to develop her techniques in the field of omics including single cell RNA seq, spatiotranscriptomic analysis, and genomics using human PBMC samples from COVID-19 vaccination with myocarditis and colonic tissues from patients with ulcerative colitis. After graduate program, Dr. Hwang has continued her research career as Research Staff in Fang Lab from March 2024.
Department of Medical Science, Ph.D. (March 2017~February 2024)
Dr. Lee has investigated the physiological roles of MOGAT1 to modulate lipid metabolism in hepatocytes. He has screened specific inhibitors for MOGAT1 to protect against NAFLD and NASH using animal models. Furthermore, Dr. Lee has expanded his interests into the molecular mechanisms of hepatic MOGAT1 to control hepatic cellular energetics in response to environmental stresses, such as nutritional stress. Dr. Lee has continued his research career as Research Staff in Genomic center, Gangnam Severance Hospital.
Department of Medical Science, Ph.D. (March 2019~February 2024)
Dr. Chun has investigated physiological roles of Dexras1 to modulate cell proliferation, drug resistance and migration in different types of gastric cancer such as intestinal vs smooth-muscle like cells. In addition, Dr. Chun has been working to identify the therapeutic targets to increase efficacy of anti-PD1 cancer drug using syngenic animal models. After trained as Research Staff in Dr. Jae-woo Kim's Lab, Dr. Chun joined Dr. Vijayanand (La Jolla Institute for Immunology) as Postdoctoral Research Associate from February 2025.
Department of Medical Science (September 2020~August 2023).
Mr. Kim has been trained to investigate molecular mechanisms of how BDNF1 controls cellular energy metabolism in response to serine-deprivation in colorectal cancer.
B.S., Yonsei University Underwood International College (March 2022~August 2023)
Mr. Yunjun Kang joined Fang Lab as Underwood College undergraduate research assistant. After being trained with scRNA seq analysis in diverse metabolic tissues, Mr. Kang joined Dr. Teddy Drivas lab, the Graduate program of Biomedical Engineering at Univ. of Pennsylvania from August 2023.
Department of Medical Science, Ph.D. (September 2019~February 2024)
Afer Master degree, Dr. Hwang joined Department of Medical Science at Yonsei University College of Medicine from Sept 2019, and he officially joined Fang lab from March 2022. For two years, Dr. Hwang has been working on 1C metabolism to control immunometabolism inflammatory CAF of CRC on the transcriptomics-based bioinformatics. Dr. Hwang joined Department of Internal Medicine as Research Staff at Yonsei University College of Medicine from January 2024.
Mr. Kim joined Fang Lab from summer 2021 as a Vanderbilt University freshman undergraduate research assistant. Even after military service, he re-joined Fang lab and started his research experience with a project related to bioinformatics. Mr. Kim currently has analyzed human and mouse COPD tissue and lung cancer tissues single cell RNA seqeuncing to identify novel relevant biomarkers.
Dr. Lee joined Fang lab from June, 2019 as Research Assistant Professor and has investigated physiological roles of E3 ligase MKRN1 to modulate various signaling networks promoting cell proliferation and tumorigenesis in response to diverse cellular environments, such as hypoxia and nutritional stress. In addition to ubiquitin-proteasome project, Dr. Lee has discovered novel therapeutic targets to improve efficacy of anti-PD-1 anticancer drugs using syngenic animal models. (June 2019~February 2024)
Department of Medical Science, Ph.D. (March 2019~August 2024)
Dr. Kim has investigated physiological roles of nuclear receptor FXR signaling that controls cellular energetics to regulate cell survival, ER stress, inflammation and tumorigenesis in colorectal cancer. By using scRNA seq, ATAC seq, and ChIP seq as well as 3C-Chip assay, Dr. Kim has investigated FXR-activated 1C metabolism to control Redox balance in colorectal cancer. Dr. Kim joined the Laboratory of Dr. Jae Hyuk Choi (Northwestern University) as Postdoctoral Research Associate from Fall 2024.
Department of Medicine, Ph.D. (March 2020~February 2025)
Dr. Jeong is a licensed medical technologist and has investigated molecular mechanisms of how Glucagon-like peptide 1 (GLP-1) secretion is modulated by nutritional status. For Ph.D. thesis, Dr. Jeong has investigated the molecular mechanisms of how epigenetic eraser controls transcriptional networks modulating cellular energetics and tumorigenesis in pancreatic cancer. After graduate program, Dr. Jeong is going to continue his research career as Research Staff in Fang Lab from March 2025.
B.S., Yonsei University Underwood International College (January 2024~June 2025)
Ms. Lee joined Fang Lab from January 2024 as a senior undergraduate research assistant. Ms. Lee has analyzed intestinal crypt scRNA seq data from aged mice to investigate the physiological impacts of exercise. She collected intestinal crypt and performed scRNA seq using intestinal crypts from sedentary and voluntary exercised old mice to identify novel relevant biomarkers and metabolic pathways. After Fang Lab training, Ms. Lee joined MD Anderson UT Health Houston Graduate School of Biomedical Sciences from August 2025.
B.S., King's College London (July 2024~June 2025)
Ms. Ko joined Fang Lab from Jul 2024 as a student intern. She has been trained to do numerous animal works and molecular techniques as well as bioinformatics analysis using R. Furthermore, Ms. Ko joined the research project about exercise effects on the senescence in intestinal crypt from aging mice. After Fang Lab training, Ms. Ko joined University College London Graduate School from August 2025.